Literature DB >> 1680787

Possible mapping of the gene for transient myeloproliferative syndrome at 21q11.2.

N Niikawa1, H X Deng, K Abe, N Harada, T Okada, H Tsuchiya, I Akaboshi, I Matsuda, Y Fukushima, Y Kaneko.   

Abstract

The parental origin of the extra chromosome 21 was studied in 20 patients with trisomy 21-associated transient myeloproliferative syndrome (TMS) using chromosomal heteromorphisms as markers; this was combined with a study of DNA polymorphisms in 5 patients. Of these, 10 were shown to result from duplication of a parental chromosome 21, viz., maternal in 8 and paternal in 2. A patient with Down syndrome-associated TMS had a paracentric inversion in two of his three chromosomes 21 [47,XY,-21,+inv(21)(q11.2q22.13)mat,+inv(21)(q11.2 q22.13)mat]. These findings support our hypothesis of "disomic homozygosity" of a mutant gene on chromosome 21 in 21-trisomic cells as being a mechanism responsible for the occurrence of TMS. The finding also suggests that the putative TMS gene locus is at either 21q11.2 or 21q22.13, assuming that the gene is interrupted at either site because of the inversion. The study of 5 TMS patients using DNA polymorphic markers detected a cross-over site on the duplicated chromosomes 21 between 21q11.2 (or q21.2) and 21q21.3 in one patient, and a site between 21q21.3 and q22.3 in another patient, evidence that confined the gene locus to the 21cen-q21.3 segment. These findings suggest that the putative TMS gene is located at 21q11.2. The extra chromosome 21 in the latter two TMS patients probably resulted from maternal second meiotic non-disjunction, in view of the presence of recombinant heterozygous segments on their duplicated chromosomes 21.

Entities:  

Mesh:

Year:  1991        PMID: 1680787     DOI: 10.1007/bf00209012

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Disomic homozygosity in 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome.

Authors:  K Abe; T Kajii; N Niikawa
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

2.  Parental origin and mechanism of formation of polysomy X: an XXXXX case and four XXXXY cases determined with RFLPs.

Authors:  H X Deng; K Abe; I Kondo; M Tsukahara; H Inagaki; I Hamada; Y Fukushima; N Niikawa
Journal:  Hum Genet       Date:  1991-04       Impact factor: 4.132

3.  Disomic homozygosity and leukemia in Down's syndrome.

Authors:  R Sansone; M Pierluigi; S Carobbi; M Cominetti; P Strigini
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

Review 4.  Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms.

Authors:  K K Kidd; A M Bowcock; J Schmidtke; R K Track; F Ricciuti; G Hutchings; A Bale; P Pearson; H F Willard; J Gelernter
Journal:  Cytogenet Cell Genet       Date:  1989

5.  Transient neonatal leukemoid reactions in mosaic trisomy 21.

Authors:  N L Seibel; A Sommer; J Miser
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Monosomy for 21pter-q21: case report and assignment of a DNA clone (Fr8-77) to the deleted segment.

Authors:  K Abe; H X Deng; N Harada; K Yoshiura; T Oh-Hira; N Niikawa
Journal:  Jinrui Idengaku Zasshi       Date:  1990-12

7.  Leukaemia and transient leukaemia in Down syndrome.

Authors:  L Iselius; P Jacobs; N Morton
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

8.  Sequential Q- and Acridine orange-marker technique.

Authors:  N Niikawa; T Kajii
Journal:  Humangenetik       Date:  1975-10-20

9.  Pseudoleukemia in Down's syndrome. Analysis of immunophenotype and gene rearrangement.

Authors:  D R Domenico; G J Dizikes; A R Melnyk; M L Bird; C R Suarez; H R Schumacher
Journal:  Am J Clin Pathol       Date:  1989-06       Impact factor: 2.493

  9 in total
  3 in total

1.  Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome.

Authors:  J Groet; J H Ives; A P South; P R Baptista; T A Jones; M L Yaspo; H Lehrach; M C Potier; C Van Broeckhoven; D Nizetić
Journal:  Genome Res       Date:  1998-04       Impact factor: 9.043

2.  Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis.

Authors:  T Ohta; M Nakano; T Tsujita; K Abe; K Osoegawa; T Yamagata; K Yoshiura; Y Jinno; E Soeda; Y Nakamura; N Niikawa
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.

Authors:  S De Vita; C Canzonetta; C Mulligan; F Delom; J Groet; C Baldo; L Vanes; F Dagna-Bricarelli; A Hoischen; J Veltman; E M C Fisher; V L J Tybulewicz; D Nizetic
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.